Market Cap 12.43M
Revenue (ttm) 0.00
Net Income (ttm) -17.54M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 201,900
Avg Vol 209,125
Day's Range N/A - N/A
Shares Out 7.53M
Stochastic %K 35%
Beta 0.70
Analysts Sell
Price Target $60.00

Company Profile

BioVie Inc., a clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease. The company develops BIV201 for the treatment of ascites due to chronic liver cirrhosis. It also develops NE3107 that is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer's disease; and in Phase 2 clinical trial to treat Parkinson's disease, as well as for the long COVID program. The company was...

Industry: Biotechnology
Sector: Healthcare
Phone: 775 888 3162
Address:
680 West Nye Lane, Suite 204, Carson City, United States
Stmkr
Stmkr Aug. 26 at 7:18 PM
$BIVI Some pumping here is long overdue. Esp with runway throught long-covid and PD readouts
0 · Reply
Sensore
Sensore Aug. 26 at 3:39 PM
0 · Reply
Thorilium
Thorilium Aug. 25 at 11:21 PM
$BIVI this company is badly managed
1 · Reply
woolpourpis69
woolpourpis69 Aug. 25 at 4:01 AM
$BIVI nobody fuckin cares in a death spiral.. nobody wins that wants to see change.. the change is everyone who had money now doesn’t.. stfu 🤡
0 · Reply
GhostGamma
GhostGamma Aug. 23 at 7:29 AM
$BIVI BioVie Inc is a clinical stage neurology company with high development risk
1 · Reply
AgentMZM
AgentMZM Aug. 23 at 1:14 AM
$BIVI great comback today. Let's shoot for $2 next week.
0 · Reply
AgentMZM
AgentMZM Aug. 22 at 1:33 PM
$BIVI all it will take is a positive new to get this stok over $10 again. You may think that you know, but only they know. Dont get left behind.
1 · Reply
Celz
Celz Aug. 21 at 7:05 PM
$BIVI good advice
0 · Reply
Thorilium
Thorilium Aug. 21 at 6:00 PM
$BIVI when you want to invest in biotech and into inflammation invest in ICU or CYDY
0 · Reply
Thorilium
Thorilium Aug. 21 at 2:21 PM
$BIVI told you this will keep dropping below 1 this company has an outdated product with no commercial value go towards CYDY or ICU also on inflammation $CYDY $ICU
0 · Reply
Latest News on BIVI
BioVie Inc. Announces Pricing of $12 Million Public Offering

Aug 7, 2025, 8:43 PM EDT - 19 days ago

BioVie Inc. Announces Pricing of $12 Million Public Offering


BioVie Inc. Announces Closing of Public Offering

Sep 25, 2024, 4:05 PM EDT - 11 months ago

BioVie Inc. Announces Closing of Public Offering


Crude Oil Gains Over 1%; BioVie Shares Plunge

Sep 24, 2024, 2:08 PM EDT - 1 year ago

Crude Oil Gains Over 1%; BioVie Shares Plunge


BioVie Inc. Announces Pricing of Public Offering

Sep 23, 2024, 10:26 PM EDT - 1 year ago

BioVie Inc. Announces Pricing of Public Offering


BioVie Inc. Announces Proposed Public Offering

Sep 23, 2024, 4:05 PM EDT - 1 year ago

BioVie Inc. Announces Proposed Public Offering


BioVie Inc. Announces Reverse Stock Split

Aug 6, 2024, 4:40 PM EDT - 1 year ago

BioVie Inc. Announces Reverse Stock Split


Stmkr
Stmkr Aug. 26 at 7:18 PM
$BIVI Some pumping here is long overdue. Esp with runway throught long-covid and PD readouts
0 · Reply
Sensore
Sensore Aug. 26 at 3:39 PM
0 · Reply
Thorilium
Thorilium Aug. 25 at 11:21 PM
$BIVI this company is badly managed
1 · Reply
woolpourpis69
woolpourpis69 Aug. 25 at 4:01 AM
$BIVI nobody fuckin cares in a death spiral.. nobody wins that wants to see change.. the change is everyone who had money now doesn’t.. stfu 🤡
0 · Reply
GhostGamma
GhostGamma Aug. 23 at 7:29 AM
$BIVI BioVie Inc is a clinical stage neurology company with high development risk
1 · Reply
AgentMZM
AgentMZM Aug. 23 at 1:14 AM
$BIVI great comback today. Let's shoot for $2 next week.
0 · Reply
AgentMZM
AgentMZM Aug. 22 at 1:33 PM
$BIVI all it will take is a positive new to get this stok over $10 again. You may think that you know, but only they know. Dont get left behind.
1 · Reply
Celz
Celz Aug. 21 at 7:05 PM
$BIVI good advice
0 · Reply
Thorilium
Thorilium Aug. 21 at 6:00 PM
$BIVI when you want to invest in biotech and into inflammation invest in ICU or CYDY
0 · Reply
Thorilium
Thorilium Aug. 21 at 2:21 PM
$BIVI told you this will keep dropping below 1 this company has an outdated product with no commercial value go towards CYDY or ICU also on inflammation $CYDY $ICU
0 · Reply
TJ12000
TJ12000 Aug. 21 at 2:16 PM
$BIVI snake oil scam company
0 · Reply
alaobaid
alaobaid Aug. 20 at 10:08 PM
0 · Reply
AgentMZM
AgentMZM Aug. 20 at 1:40 PM
0 · Reply
Thorilium
Thorilium Aug. 20 at 7:33 AM
$BIVI this is crashing...I wonder why they are still people bullish about this stock, there are so many companies in this space that even when successful the market share will be limited and lots of cash needs to be spend to promote the drug so probably not that profitable... unfortunately ... looked good but is a total failure so far
0 · Reply
Thorilium
Thorilium Aug. 20 at 7:27 AM
$BIVI this will go below 1...this company failed, putting lot's of efforts to stay listed while imo that money could have been better used to do more research
0 · Reply
Sensore
Sensore Aug. 19 at 3:38 PM
0 · Reply
AgentMZM
AgentMZM Aug. 19 at 1:29 PM
0 · Reply
Sensore
Sensore Aug. 19 at 11:56 AM
0 · Reply
AgentMZM
AgentMZM Aug. 18 at 5:59 PM
0 · Reply
BomBeur
BomBeur Aug. 18 at 5:53 PM
0 · Reply
ForestFoxes
ForestFoxes Aug. 18 at 12:02 PM
$ANVS investors new and old should have lots of confidence as the drug is “more promising than any Alzheimer drug on the market or in development” according to a March 2, 2025 public declaration on Stocktwits by the CEO. The CEO clearly knows what she’s doing in her own mind with a degree of certainty greater than a 100%. Even CFOs are superfluous given her own repeated historic actions on removing CFOs and taking on the role herself! https://stocktwits.com/ForestFoxes/message/625572410 She’s a superior CEO who has often stated on the record that she is 900% certain her drug works. That’s why she’s willing to hold a Patient’s Live Forum and tells patients and their families to “Buy stock! It’s the ONLY way out!”. Other investors in biotech companies in the same space such as $CGTX $AVXL $SAVA and $BIVI must comparatively ask themselves: Is my CEO this committed to creating shareholder value and bringing a drug to Market at this level of confidence and competence? Why does my CEO bother to have a CFO? Or, any MDs on their staff? Or, accurately share scientific based PRs? Or, bother to listen to their attorneys? Or, accurately compete documents to the SEC when selectively submitted, or … Does your CEO repeatedly tell you that she’s very good at designing drug trials?? Best 🏆 CEO? @adamfeuerstein a senior writer and biotech columnist for STAT News, is known for his annual "Best and Worst Biopharma CEO" rankings. He does not have a "CEO of the Year" award himself, but rather, he conducts a poll to determine the best and worst in the biopharma industry. In his 2024 rankings, Remi Barbier of Cassava Sciences was named the "Worst Biopharma CEO". For the "Best Biopharma CEO" category, "The team that developed [Cobenfy] successfully" and the "smartly acquired" Karuna Therapeutics, along with Eli Lilly's David Ricks (who was also the Best Biopharma CEO of 2023), were recognized. https://www.statnews.com/2024/12/18/worst-biopharma-ceo-2024-remi-barbier-cassava-sciences/#:~:text=Remi%20Barbier%2C%20the%20former%20CEO,had%20a%20very%20bad%20year&text=Adam%20Feuerstein%20is%20a%20senior,doing%20annually%20for%2017%20years.&text=Barbier%20had%20a%20bad%20year,shareholder%20and%20class%2Daction%20lawsuits. Annovis Bio investors must be 👉 900%
1 · Reply
Thorilium
Thorilium Aug. 18 at 6:43 AM
$BIVI this week below 1? I do not see this hitting 10 Inflammation battle is over imo...and BIVI lost
1 · Reply